CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Association Between Depressive Symptoms and Incident Cardiovascular Diseases High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines

F Cosentino, PJ Grant, ESC Scientific Document Group et al. Keywords: guidelines; diabetes mellitus; impaired glucose tolerance; cardiovascular diseases; epidemiology; risk factors; prevention; cardiovascular risk assessment; patient management; pharmacological treatment; revascularization; patient-centred care

FULL TEXT PDF